The neurotechnology sector holds promise to deliver treatments for CNS disorders for which the unmet need is high. Over the last decade, significant advances have taken place in this field, driven by venture investment and strategic partnerships. Now in its 15th year, the Neurotech Investing and Partnering Conference is the premier partnering and investing conference for the neurotechnology industry, spanning pharmaceuticals, medical devices, software, and diagnostics for the brain and nervous system. The event features keynotes, investor panels, and cutting edge company presentations on a comprehensive selection of neurotech topics including pharmaceuticals, diagnostics, imaging and medical devices.
Previous years events have pulled a full house of over 150 investors and executives for two days of discussion and superb high-level networking. Companies engaged in this event focus on diverse areas of major unmet need including Alzheimer’s, addiction,
anxiety, depression, multiple sclerosis, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, Parkinson’s, and traumatic injury. The event also features an Emerging Company Showcase giving time on the main stage to young neurotech start-ups to pitch their company to our audience of investors and executives.
This year’s event promises to continue a tradition of carefully curated, high-quality content and invaluable networking. Facilitated networking opportunities and partnering tools provide an ideal venue to connect investors with potential partners and launch the new relationships that will grow into tomorrow’s successful treatments and partnerships. We hope you will join us in our goal of accelerating neurotechnology through investment and collaboration.